Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study

Giovanna Mantini, Valeria Valentini, Bruno Meduri, Stefano Margaritora, Mario Balducci, Francesco Micciché, Luigia Nardone, Fiorenza De Rose, Alfredo Cesario, Anna Rita Larici, Fabio Maggi, Maria Lucia Calcagni, Pierluigi Granone

Risultato della ricerca: Contributo in rivistaArticolo in rivista

13 Citazioni (Scopus)

Abstract

Low-dose radiotherapy (LDR) (<50 cGy) induces enhanced cell killing in vitro via the hyper-radiation sensitivity phenomenon. Aim of this study was to evaluate the safety and efficacy of a palliative regimen combining pemetrexed and LDR (as a chemopotentiator) on patients affected by recurrent non-small-cell lung cancer (NSCLC).
Lingua originaleEnglish
pagine (da-a)161-166
Numero di pagine6
RivistaRadiotherapy and Oncology
Volume105
DOI
Stato di pubblicazionePubblicato - 2012

Keywords

  • nsclc

Fingerprint

Entra nei temi di ricerca di 'Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: a prospective phase II study'. Insieme formano una fingerprint unica.

Cita questo